CCL17 and classic Hodgkin lymphoma: The designed biosensor with lower and upper quantitation limits of 387 and 50,000 pg/mL towards CCL17/TARC showed a high dynamic range compared to the equivalent colorimetric ELISA platform, implying an essential step towards developing a rapid test for the staging and treatment of cHL.